Alexis O'Neil
Sessions in which Alexis O'Neil attends
Friday 16 June, 2023
Learning Objectives: At the end of this session, participants will be able to: Explain the mechanism of action of the major immune checkpoint inhibitors currently used in cancer immunotherapyDiscuss the
Learning Objectives: At the end of this session, participants will be able to: Assess the use of multi-modal imaging in assessing retinal pathologyAssess new technologies in imaging of the retinaIntegrate new management strategies for diabetic retinopathyCanMEDS Roles: Medical Expert, Scholar
Saturday 17 June, 2023
Learning Objectives:At the end of this session, participants will be able to:Elucidate the cause and mechanism of DVD.Identity indications of Light adjustable lensXX
Learning ObjectivesAt the end of this session, participants will be able to:Understand what is meant by cortical visual impairment Appreciate the impact of visual impairment on mental healthBe able to assess the needs of a child with visual impairment CanMEDS Roles: Medical ...
Learning ObjectivesAt the end of this session participants will be able to:Describe the impact of AI technologies on eye care Understand the unique aspects of eye health needs in remote populations C...
Learning ObjectivesAt the end of this session participants will be able to:Describe the impact of AI technologies on eye care Understand the unique aspects of eye health needs in remote populationsCompare various models of care for remote populations in low and middle-income countries CanMeds Roles: Professional, Health Advocate
Learning ObjectivesAt the end of this session, participants will be able to:Understand the pre and post-natal screening of retinoblastoma Learn the accuracy of IOL calculation formulas in Children
Sunday 18 June, 2023
Learning Objectives:At the end of this session, participants will be able to:Understand current evaluation and intervention approaches in pediatric vision rehabilitation.Understand the role of organisms and the microbiome in corneal infectionsReview management strategies for mild to severe keratoconusXX